Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Multiple Sclerosis

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 36 articles:
HTML format
Text format



Single Articles


    January 2012
  1. KREFT KL , Verbraak E, Wierenga-Wolf AF, van Meurs M, et al
    The IL-7Ralpha Pathway Is Quantitatively and Functionally Altered in CD8 T Cells in Multiple Sclerosis.
    J Immunol. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. CONTI L , De Palma R, Rolla S, Boselli D, et al
    Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-gammaR2.
    J Immunol. 2012.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  3. SMARR CB , Hsu CL, Byrne AJ, Miller SD, et al
    Antigen-Fixed Leukocytes Tolerize Th2 Responses in Mouse Models of Allergy.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  4. SCHNEIDER R , Mohebiany AN, Ifergan I, Beauseigle D, et al
    B Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and Is Increased in Multiple Sclerosis Patients.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  5. ZHANG X , Tao Y, Troiani L, Markovic-Plese S, et al
    Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



  6. KOFLER DM , Severson CA, Mousissian N, De Jager PL, et al
    The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+ T Cell Proliferation.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



  7. ZHANG J , Zhang Y, Dutta DJ, Argaw AT, et al
    Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11.
    J Immunol. 2011;187:1129-41.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  8. KEERTHIVASAN S , Suleiman R, Lawlor R, Roderick J, et al
    Notch signaling regulates mouse and human Th17 differentiation.
    J Immunol. 2011;187:692-701.
    PubMed     Text format     Related articles    Abstract available



  9. THAKKER P , Marusic S, Stedman NL, Lee KL, et al
    Cytosolic Phospholipase A2{alpha} Blockade Abrogates Disease during the Tissue-Damage Effector Phase of Experimental Autoimmune Encephalomyelitis by Its Action on APCs.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



  10. VAN NOORT JM , Amor S, Bajramovic JJ
    Comment on "Chaperone Activity of {alpha} B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis".
    J Immunol. 2011;187:3.
    PubMed     Text format     Related articles   



    June 2011
  11. JIANG W , Chai NR, Maric D, Bielekova B, et al
    Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



  12. RADDASSI K , Kent SC, Yang J, Bourcier K, et al
    Increased Frequencies of Myelin Oligodendrocyte Glycoprotein/MHC Class II-Binding CD4 Cells in Patients with Multiple Sclerosis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  13. JOHNSON TA , Evans BL, Durafourt BA, Blain M, et al
    Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  14. DISANTO G , Handel AE, Morahan JM, Ramagopalan SV, et al
    Comment on "Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice".
    J Immunol. 2011;186:3803-4.
    PubMed     Text format     Related articles   



    March 2011
  15. RAMGOLAM VS , Sha Y, Marcus KL, Choudhary N, et al
    B Cells as a Therapeutic Target for IFN-{beta} in Relapsing-Remitting Multiple Sclerosis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  16. ROTHBARD JB , Zhao X, Sharpe O, Strohman MJ, et al
    Chaperone Activity of α B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



  17. SAYED BA , Walker ME, Brown MA
    Cutting Edge: Mast Cells Regulate Disease Severity in a Relapsing-Remitting Model of Multiple Sclerosis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



  18. RACKE MK , Lovett-Racke AE
    Glatiramer acetate treatment of multiple sclerosis: an immunological perspective.
    J Immunol. 2011;186:1887-90.
    PubMed     Text format     Related articles    Abstract available



  19. BAECHER-ALLAN CM , Costantino CM, Cvetanovich GL, Ashley CW, et al
    CD2 Costimulation Reveals Defective Activity by Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  20. HANDEL AE , De Luca GC, Ramagopalan SV
    Comment on "gender differences in 1,25 dihydroxyvitamin d3 immunomodulatory effects in multiple sclerosis patients and healthy subjects".
    J Immunol. 2011;186:647.
    PubMed     Text format     Related articles   



  21. JANSON PC , Linton LB, Bergman EA, Marits P, et al
    Profiling of CD4+ T cells with epigenetic immune lineage analysis.
    J Immunol. 2011;186:92-102.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  22. GALGANI M , Procaccini C, De Rosa V, Carbone F, et al
    Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway.
    J Immunol. 2010;185:7474-9.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  23. MC GUIRE C , Volckaert T, Wolke U, Sze M, et al
    Oligodendrocyte-Specific FADD Deletion Protects Mice from Autoimmune-Mediated Demyelination.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



  24. BEYEEN AD , Adzemovic MZ, Ockinger J, Stridh P, et al
    IL-22RA2 Associates with Multiple Sclerosis and Macrophage Effector Mechanisms in Experimental Neuroinflammation.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  25. SAIKALI P , Antel JP, Pittet CL, Newcombe J, et al
    Contribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple Sclerosis.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



  26. CAMINA-TATO M , Morcillo-Suarez C, Bustamante MF, Ortega I, et al
    Gender-Associated Differences of Perforin Polymorphisms in the Susceptibility to Multiple Sclerosis.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  27. CORREALE J , Ysrraelit MC, Gaitan MI
    Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  28. KOLLN J , Zhang Y, Thai G, Demetriou M, et al
    Inhibition of Glyceraldehyde-3-Phosphate Dehydrogenase Activity by Antibodies Present in the Cerebrospinal Fluid of Patients with Multiple Sclerosis.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



  29. SOMERFIELD J , Hill-Cawthorne GA, Lin A, Zandi MS, et al
    A novel strategy to reduce the immunogenicity of biological therapies.
    J Immunol. 2010;185:763-8.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  30. GRIS D , Ye Z, Iocca HA, Wen H, et al
    NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



  31. BRAHMACHARI S , Pahan K
    Gender-Specific Expression of {beta}1 Integrin of VLA-4 in Myelin Basic Protein-Primed T Cells: Implications for Gender Bias in Multiple Sclerosis.
    J Immunol. 2010;184:6103-13.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  32. LIU H , Fitzgerald D, Gran B, Leong JM, et al
    Induction of distinct neurologic disease manifestations during relapsing fever requires T lymphocytes.
    J Immunol. 2010;184:5859-64.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  33. SCHWAB N , Zozulya AL, Kieseier BC, Toyka KV, et al
    An Imbalance of Two Functionally and Phenotypically Different Subsets of Plasmacytoid Dendritic Cells Characterizes the Dysfunctional Immune Regulation in Multiple Sclerosis.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



  34. NILAND B , Miklossy G, Banki K, Biddison WE, et al
    Cleavage of Transaldolase by Granzyme B Causes the Loss of Enzymatic Activity with Retention of Antigenicity for Multiple Sclerosis Patients.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



  35. HOE E , McKay FC, Schibeci SD, Gandhi K, et al
    Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells.
    J Immunol. 2010;184:2512-7.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  36. DELUCA LE , Pikor NB, O'Leary J, Galicia-Rosas G, et al
    Substrain Differences Reveal Novel Disease-Modifying Gene Candidates That Alter the Clinical Course of a Rodent Model of Multiple Sclerosis.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.

   Design: